Novanta (NOVT) Cash & Equivalents (2016 - 2025)
Novanta's Cash & Equivalents history spans 16 years, with the latest figure at $380.9 million for Q4 2025.
- For Q4 2025, Cash & Equivalents rose 234.13% year-over-year to $380.9 million; the TTM value through Dec 2025 reached $380.9 million, up 234.13%, while the annual FY2025 figure was $380.9 million, 234.13% up from the prior year.
- Cash & Equivalents reached $380.9 million in Q4 2025 per NOVT's latest filing, up from $89.2 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $380.9 million in Q4 2025 to a low of $76.0 million in Q3 2023.
- Average Cash & Equivalents over 5 years is $114.5 million, with a median of $100.3 million recorded in 2022.
- Peak YoY movement for Cash & Equivalents: decreased 24.93% in 2022, then soared 234.13% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $117.4 million in 2021, then dropped by 14.73% to $100.1 million in 2022, then rose by 4.94% to $105.1 million in 2023, then increased by 8.51% to $114.0 million in 2024, then skyrocketed by 234.13% to $380.9 million in 2025.
- Per Business Quant, the three most recent readings for NOVT's Cash & Equivalents are $380.9 million (Q4 2025), $89.2 million (Q3 2025), and $109.9 million (Q2 2025).